Adding radiation to induction chemotherapy does not improve survival of patients with operable clinical N2 non–small cell lung cancer
Chi‐Fu Jeffrey Yang, Brian C. Gulack, Lin Gu et al. · Journal of Thoracic and Cardiovascular Surgery · 2015
Cited by 30 works. doi:10.1016/j.jtcvs.2015.06.062 Open-access PDF
Authors
- Chi‐Fu Jeffrey Yang
- Brian C. Gulack
- Lin Gu
- Paul J. Speicher
- Xiaofei Wang
- David H. Harpole
- Mark W. Onaitis
- Thomas Anthony D’Amico
- Mark F. Berry
- Matthew Galen Hartwig
References
- AJCC Cancer Staging Manual
- AJCC Cancer Staging Manual
- Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer
- Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial
- Non-Small Cell Lung Cancer
- Non–Small Cell Lung Cancer
- Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non-Small-Cell Lung Cancer
- Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
- Treatment of Non-small Cell Lung Cancer-Stage IIIA
- Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial